SQI DIAGNOSTICS INC (SQD.CA) Stock Price, Forecast & Analysis
Canada - TSX-V:SQD - CA78466B1085 - Common Stock
SQD.CA Key Statistics, Chart & Performance
The current stock price of SQD.CA is 0.015 CAD. In the past month the price decreased by -76.92%. In the past year, price decreased by -91.18%.
SQD.CA Latest News, Press Relases and Analysis
SQD.CA Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| PRN.CA | PROFOUND MEDICAL CORP | N/A | 252.10M | ||
| MIR.CA | MEDMIRA INC | N/A | 56.87M | ||
| TLT.CA | THERALASE TECHNOLOGIES INC | N/A | 48.32M | ||
| CNVI.CA | CONAVI MEDICAL CORP | N/A | 46.82M | ||
| PINK.CA | PERIMETER MEDICAL IMAGING AI | N/A | 27.91M | ||
| ASG.CA | AURORA SPINE CORP | N/A | 22.78M | ||
| NSCI.CA | NANALYSIS SCIENTIFIC CORP | N/A | 20.67M | ||
| MDX.CA | MEDX HEALTH CORP | N/A | 18.53M | ||
| VPT.CA | VENTRIPOINT DIAGNOSTICS LTD | N/A | 16.77M | ||
| THRM.CA | THERMA BRIGHT INC | N/A | 3.98M | ||
| VER-H.CA | VERISANTE TECHNOLOGY INC | N/A | 439.40K | ||
| VVTM.CA | VVT MED INC | N/A | 20.05M |
Related stock screener links
About SQD.CA
Company Profile
SQI Diagnostics, Inc. engages in developing and selling testing kits, services, and automated testing systems to clinical laboratories, hospitals, clinicians, and diagnostic testing companies. The company is headquartered in Etobicoke, Ontario. The company went IPO on 2005-02-09. The firm develops and manufactures respiratory health and precision medicine tests that run on structured query language (SQI) fully automated systems. Its tests enhance COVID-19 antibody monitoring, rapid acute lung injury testing, donor organ transplant informatics, and immunological protein and antibody testing. Its COVID-19 testing solutions include Rapid Mobile PCR Testing for COVID-19, Sofia SARS Antigen Fluorescent Immunoassay (FIA) and Sofia2 Flu+SARS Antigen Fluorescent Immunoassay (FIA). Its transplant diagnostics solutions include TORdx LUNG Test, which is a diagnostic that assesses the health of donor lungs, and Ex Vivo Lung Perfusion provides care for conditioning donor lungs suspected of injury prior to transplantation. The company also offers surveillance testing such as Celiac Disease Screening Test and Rheumatoid Arthritis Test.
Company Info
SQI DIAGNOSTICS INC
36 Meteor Dr
Etobicoke ONTARIO M9W 1A4 CA
CEO: Rob Chioini
Employees: 0
Phone: 14166749500.0
SQI DIAGNOSTICS INC / SQD.CA FAQ
What does SQD do?
SQI Diagnostics, Inc. engages in developing and selling testing kits, services, and automated testing systems to clinical laboratories, hospitals, clinicians, and diagnostic testing companies. The company is headquartered in Etobicoke, Ontario. The company went IPO on 2005-02-09. The firm develops and manufactures respiratory health and precision medicine tests that run on structured query language (SQI) fully automated systems. Its tests enhance COVID-19 antibody monitoring, rapid acute lung injury testing, donor organ transplant informatics, and immunological protein and antibody testing. Its COVID-19 testing solutions include Rapid Mobile PCR Testing for COVID-19, Sofia SARS Antigen Fluorescent Immunoassay (FIA) and Sofia2 Flu+SARS Antigen Fluorescent Immunoassay (FIA). Its transplant diagnostics solutions include TORdx LUNG Test, which is a diagnostic that assesses the health of donor lungs, and Ex Vivo Lung Perfusion provides care for conditioning donor lungs suspected of injury prior to transplantation. The company also offers surveillance testing such as Celiac Disease Screening Test and Rheumatoid Arthritis Test.
Can you provide the latest stock price for SQI DIAGNOSTICS INC?
The current stock price of SQD.CA is 0.015 CAD.
What is the dividend status of SQI DIAGNOSTICS INC?
SQD.CA does not pay a dividend.
What is the ChartMill technical and fundamental rating of SQD stock?
SQD.CA has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 1 out of 10.
Which stock exchange lists SQD stock?
SQD.CA stock is listed on the TSX Venture Exchange exchange.
What is the market capitalization of SQD stock?
SQI DIAGNOSTICS INC (SQD.CA) has a market capitalization of 6.11M CAD. This makes SQD.CA a Nano Cap stock.
Can you provide the ownership details for SQD stock?
You can find the ownership structure of SQI DIAGNOSTICS INC (SQD.CA) on the Ownership tab.
SQD.CA Technical Analysis
SQD.CA Fundamental Analysis
ChartMill assigns a fundamental rating of 1 / 10 to SQD.CA. Both the profitability and financial health of SQD.CA have multiple concerns.
SQD.CA Financial Highlights
Over the last trailing twelve months SQD.CA reported a non-GAAP Earnings per Share(EPS) of -0.05. The EPS decreased by -16.39% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | N/A | ||
| ROE | N/A | ||
| Debt/Equity | N/A |